COVID-19 Resources

Insights from PreScouter's experts to support decision makers and the public during the pandemic.

How COVID-19 is catalyzing innovation for the chemical industry

The COVID-19 pandemic has brought about unprecedented disruption in the functioning of several industries and widespread economic hardship for businesses and consumers alike. However, the...


Sample Briefing

Renewable Energies: The Place To Go

– COVID-19 has impacted all industries and renewable energy is no exception. The present document aims...

Home medical devices: Security and regulations

– Modern technology has brought about an evolution in medical devices, making them smaller, more accurate,...
Sample Briefing

How COVID-19 Is Driving Innovation In The Food & Beverage Industry

– To date, there have been over 10 million confirmed cases and over 500,000 deaths due...

Season 1, Episode 3 – Aging Life Care Managers

– In this episode, we’ll take a closer look at how individuals who specialize in caring...


Sample Briefing

COVID-19 & Natural Resources: How To Continue Operations Safely

– The natural resources sector has been significantly disrupted by the COVID-19 pandemic due to closures...
Sample Briefing

How Can Workplaces Offer COVID-19 Testing?

– In this report, we detail all of the currently available COVID-19 workplace testing options, detailing...
White Paper

Additive Manufacturing in High Tech

– Additive manufacturing (AM) for high tech applications is beginning to emerge in the industry. This...
Sample Briefing

When will the COVID-19 pandemic end?

– In this report, we’ll cover what companies can do sustain, and even grow, in this...
White Paper

Operating Workplaces: How to keep manufacturing during the COVID-19 pandemic

– Following best practices for social distancing, hygiene and disinfection is crucial for manufacturing-centric workplaces. By...
Sample Briefing

Manufacturing challenges of critical COVID-19 medical equipment and how the industry is responding

– The COVID-19 pandemic has very clearly shown that most of the world is lagging in...
Sample Briefing

Emerging disinfection technologies for manufacturers and consumers

– In light of the current COVID-19 pandemic, we are seeing an upsurge in novel technologies...

Covid-19: Impacts & sufferings in the global auto industry

– Experts and analysts say the coronavirus pandemic has crippled the global economy worse than the...



GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine

– GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining...

Regeneron Announces Manufacturing and Supply Agreement for REGN-COV2 Anti-Viral Antibody Cocktail

– Regeneron Pharmaceuticals, Inc. announced that, as part of Operation Warp Speed, the Biomedical Advanced Research...

Novavax Announces $1.6 Billion Funding from Operation Warp Speed

– Novavax, Inc. received 1.6 billion from Operation Warp Speed (OWS), a U.S. government program aiming...

INOVIO Announces Positive Phase 1 Data For COVID-19 Vaccine

– INOVIO, a biotech company announced positive interim clinical data of INO-4800, its vaccine candidate against...

FDA to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines

– FDA issues guidelines to help facilitate the timely development of safe and effective vaccines to...

Publication of Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity in Nano Letters

– Cellics Therapeutics, Inc. announced that the results of their study evaluating the potential benefits of...

FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine

– FDA has revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate donated...

Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19

– Oxford University study shows that low doses of a long-used steroid Dexamethasone could be the...

Never miss an insight

Get insights delivered right to your inbox

You have successfully subscribed to our newsletter.

Too many subscribe attempts for this email address.